About the Authors

Ekkehard Schütz

Affiliation Chronix Biomedical, Göttingen, Germany

Anna Fischer

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Julia Beck

Affiliation Chronix Biomedical, Göttingen, Germany

Markus Harden

Affiliation Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany

Martina Koch

Affiliation Department of Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Tilo Wuensch

Affiliation Department of Surgery, Charité–Universitätsmedizin Berlin, Berlin, Germany

Martin Stockmann

Affiliation Department of Surgery, Charité–Universitätsmedizin Berlin, Berlin, Germany

Björn Nashan

Affiliation Department of Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Otto Kollmar

Affiliation Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany

Johannes Matthaei

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Philipp Kanzow

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Philip D. Walson

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Jürgen Brockmöller

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Michael Oellerich

michael.oellerich@med.uni-goettingen.de

Affiliation Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: ES and JBe are employees of, and own stock and intellectual property rights at Chronix Biomedical, which provided parts of the reagents. MO acts as consultant and advisor to Chronix Biomedical. MK has received research grants from, and honoraria for speaking at Novartis and Teva. PDW was previously been a paid consultant to Chronix Biomedical. MH has served two paid internships in 2013 and 2014 at the Novartis Pharma AG. MH's position at the university was partly funded by the research project the analyses are based on (Federal Ministry of Education and Research (BMBF): "Personalized Immunosuppression after Liver Transplantation: an observational study on the utility and therapeutic ranges of innovative biomarkers"). MH has also received grants from the Federal Ministry of Education and Research for other research projects.

Author Contributions

Conceptualization: ES MO MK TW MS BN OK JM PK JBr. Data curation: MO AF PK. Formal analysis: ES MO JBe AF MH MK TW MS BN OK PK PDW. Investigation: ES MO JBe AF MK TW MS BN OK PK PDW JBr. Methodology: ES MO JBe. Software: MH. Validation: ES MO JBe AF MH PK PDW. Writing – original draft: ES MO PDW. Writing – review & editing: ES AF JBe MH MK TW MS BN OK JM PK PDW JBr MO.